We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ipso Ventures | LSE:IPS | London | Ordinary Share | GB00B1GDWB47 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.425 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
21/9/2011 16:06 | NOT a T tradeable stock - its one for a hold preferably medium term --- | tomboyb | |
21/9/2011 13:29 | Moving up nicely again, news imminent maybe? | 27macca | |
21/9/2011 13:28 | I added at 3.25 but not showing | johncraven | |
21/9/2011 13:22 | WINS on the BID - They had been on the offer throughout the last few days. | tomboyb | |
21/9/2011 13:13 | No - but take your arguments elsewhere! | tomboyb | |
21/9/2011 13:11 | tomboyb I'm no pump and dumper ? | kinghorm23 | |
21/9/2011 13:11 | Kingphorm - i'll think i add you to that list as well - | tomboyb | |
21/9/2011 13:10 | ello ello ello what going on here then... | chesty1 | |
21/9/2011 13:09 | So long as the pump and dump crew of topinfo/falia and moreforus stay away this time ! | kinghorm23 | |
21/9/2011 13:07 | looks like this might get going bourght a few more today. | johncraven | |
21/9/2011 11:16 | Cheers Tom, Yeap! agree with you for ATUK - Huge Potential. I'm doing my research on IPS now. Nick | nick2008 | |
21/9/2011 11:12 | Hi Nick - I don't comment too much on my investments but there are'nt too many like ATUK - If ATUK can deliver what is given on the broker note then there is significant upside to be had - It is dependent on management first and foremost which in my books makes it a worthwhile investment - | tomboyb | |
21/9/2011 11:04 | Cheers tom. | lufc5 | |
21/9/2011 10:53 | Hi Tomboyb, Looking into this as potential investment. Not bought yet...... R u still in atuk? haven't seen you there for sometime. Nick | nick2008 | |
21/9/2011 10:12 | Thank you tomboy, much better. DC | daicaprice | |
21/9/2011 10:08 | Updated with Daily charts -- -- | tomboyb | |
21/9/2011 09:54 | Daily chart?????? | lufc5 | |
21/9/2011 09:49 | Which is why i have a medium term stake here - they talked on cash flow yet they did not research the company at all. £155k now for a minimum of 12 months BEFORE any disposals. Secondly - the value now is in the equity of the company. dyor. | tomboyb | |
21/9/2011 09:31 | To me IPS looks like another AGL in time so have bought a few to hold long term. | wskill | |
21/9/2011 09:27 | L2 shifted now 2 v 1 - buying at full quote -- | tomboyb | |
21/9/2011 07:33 | Cashburn? In case you can't read - the placing of £155k is enough for a minimum 12 months. Yes - that is before any disposals IPS has and management have significantly been restructured. | tomboyb | |
21/9/2011 00:06 | Give it up Tom... it is on life support.. the paymetn to therakind may be a few hundred £000 and IPS get 36% eventually -cash burn is killingand if revenues dont come in then it is fund raising!!!! | electrick | |
20/9/2011 22:07 | Therakind has: secured agreement of a Paediatric Investigation Plan (PIP) for its first product, Buccolam™, an oromucosal (buccal) solution of midazolam hydrochloride for the rapid treatment of children suffering from acute epileptic seizures. A clinical study, sponsored by Therakind, was recently conducted in Germany and the authorised product is expected to be available in 2011. secured "fast track" marketing approval status from the MHRA (UK Medicines and Healthcare products Regulatory Agency) for its second product, a collaborative project with another UK pharma company, for paediatric pain control. Clinical trials are ongoing. a strong pipeline of further products, actively progressing with other partners to secure regulatory approvals. | tomboyb | |
20/9/2011 22:03 | Buccolam "The European Commission granted a marketing authorisation valid throughout the European Union for Buccolam on 5 September 2011." Therakind due that milestone payment on marketing approval - Now lodged at the european medicenes agency. | tomboyb |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions